MCL1 and head and neck squamous cell carcinoma: Metformin-mediated down-regulation of this protein did not appear to be only caused by global translational inhibition, as observed for Mcl-1 in metformin-treated head and neck squamous cell carcinoma cell lines [26], since Mcl-1 reduction was associated with increased Noxa expression.